热门资讯> 正文
CYCC、CETX和NRXP均为上市前输家
2024-05-01 20:34
- Losers: Cemtrex (CETX) -39%.
- CVRx (CVRX) -30% after Q1 earnings release.
- NRX Pharmaceuticals (NRXP) -19%.
- Global Mofy Metaverse Ltd (GMM) -16%.
- Skyworks Solutions (SWKS) -15% after Q2 earnings release.
- Leggett & Platt (LEG) -13% after Q1 earnings release.
- Starbucks Corp. (SBUX) -13% after Q2 earnings release.
- CVS Health Corp (CVS) -12% after Q1 earnings release.
- Cyclacel Pharmaceuticals (CYCC) -11%.
- Super Micro Computer (SMCI) -10% after Q3 earnings release.
- Polestar Automotive Holding (PSNY) -7% delays release of FY 2023 results.
- mF International Ltd (MFI) -7%.
- Advanced Micro Devices (AMD) -6% after Q1 earnings release.
- NewGenIvf Group Ltd (NIVF) -5%.
More on pre-market losers & stocks.
- NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript
- Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
- Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript
- NRx Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
- NRx Pharmaceuticals announces proposed underwritten public offering of common stock
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
